Skip to content

BCPC

NASDAQ

Balchem Corp

Materials
Chemicals

$161.75

0.7%

Updated Today 3:42 PM ET

Report Card

BCPC at a glance — five pillars scored 0–100 from real filed financials.

Value
Growth
Profitability
0
Health
0
Dividends
0

Overall: Unrated · 0/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.

Key Metrics

Market Cap

$0.00

P/E

Forward P/E (est.)

ROE

Revenue Growth

EPS Growth

Profit Margin

FCF Yield

Debt / Equity

ROIC

11.0%

Interest Coverage

27.75x

Current Ratio

2.55x

Dividend Yield

Implied Growth (rev. DCF)

Rating Score

0/100

Business Overview
Research

Balchem Corp (BCPC) is a small-cap company in the Chemicals industry, part of the Materials sector of the S&P 500.

In its latest reported year it generated about $1.04B in revenue and $154.84M in net profit.

Our model rates BCPC Unrated (0/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.

Economic Moat

Evidence of durable competitive advantage in the filed financials (10 years of history).

Narrow moat signalsMoat evidence score: 66/100

Some durable-advantage evidence, but not across the board — dig into which ingredient is weak and whether it's cyclical or structural.

Gross margin level36/100

34.6% average over the last 3 years

Gross margin stability78/100

±1.8 pts around 32.5% across 10 years

Revenue durability89/100

grew in 8 of the last 9 year-over-year periods

Free-cash-flow consistency100/100

positive in 10 of 10 years

Return on invested capital30/100

11.0% latest fiscal year

A moat can't be proven by numbers alone — this scores the evidence a durable advantage leaves behind (pricing power, consistency, returns on capital), computed the same way for every stock. Pair it with the business overview before concluding anything.

Revenue Growth
Research

4Y CAGR

6.7%

Revenue moved from $553.20M in 2016 to $1.04B in 2025, a 7.2% compound annual growth rate. The most recent year was roughly steady year over year. Slower, mature growth is common for established businesses.

Profitability
1/1 checks passedROIC above 10%

Gross Margin

35.7%

Operating Margin

20.2%

Net Margin

14.9%

ROE

Debt Analysis
Research
2/2 checks passedInterest covered 3×+Short-term bills covered

Total Debt

$235.11M

Net Debt

$162.24M

Net Debt / EBITDA

0.78x

Debt / Equity

Leverage: debt-to-equity is n/a, and operating profit covers interest about 27.8x, with a current ratio of 2.5x. Detailed balance-sheet leverage is limited for this name. It carries roughly $235.11M of total debt against $72.87M of cash.

Cash Flow Analysis
Research

Operating CF

$216.56M

Free Cash Flow

$216.56M

FCF Margin

20.9%

In the latest year Balchem Corp produced about $216.56M of operating cash flow and $216.56M of free cash flow after capital spending. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.

Dividend Safety

Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.

SafeSafety score: 100/100

The payout is comfortably covered by cash the business actually generates, with a raise habit behind it.

Per share (latest FY)

$0.96

Total paid (latest FY)

$28.29M

History on record

10 years

Free-cash-flow coverage100/100

dividend uses 13% of free cash flow

Earnings payout ratio100/100

18% of net income paid out

Raise streak100/100

total dividends increased 9 years in a row

Cut history100/100

no cuts in the last 10 years on record

Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.

Valuation Analysis
Research

P/E

P/S

P/B

EV / EBITDA

BCPC trades at n/a trailing earnings. With no positive trailing earnings, value it on sales, cash flow, or growth rather than P/E.

Metrics vs. Sector Range

Where BCPC sits versus its Materials sector peers in the S&P 500.

TTM P/E
Forward P/E
P/S ratio
Revenue growth
EPS growth
Gross margin
35.7%Average
Net margin
ROE

Bands show the middle half (25th–75th percentile) of the 54 Materials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.

Sector Peer Comparison

How BCPC stacks up against its Materials peers — valuation, profitability, and growth versus the sector median.

In the Materials sector (78 S&P 500 companies), BCPC ranks #58 of 78 by our overall rating.

P/E vs sector

median 21.5x

ROE vs sector

median 16.1%

Growth vs sector

median 7.9%

Sector rank

#58

of 78 by rating

CompanyP/ERev Gr.Rating
BCPCThis stockNot rated
HWKNNot rated
IOSPNot rated
MEOHNot rated
PCTNot rated
SOLSNot rated
ESI71.5x13.0%Weak· 29
WLK-8.6%Weak· 26
Materials median21.5x7.9%46/100
Compare side by side

Peers are the closest Materials companies by sub-industry and size. Sector median is across all 78 S&P 500 names in the sector. Educational, not a recommendation.

5-Year Projection Model

Project revenue → earnings → price. Edit the assumptions to build your own case.

2030 price target (Base Case)

$0.00 $0.00

vs. $161.75 today · expected CAGR -12%-3%

Metric20262027202820292030
Revenue$1.12B$1.21B$1.31B$1.41B$1.52B
Net income$168.02M$181.46M$195.98M$211.66M$228.59M
EPS$5.23$5.65$6.10$6.59$7.11
Share price (low)$62.75$67.77$73.20$79.05$85.37
Share price (high)$104.59$112.96$121.99$131.75$142.29
CAGR (low–high)-61% / -35%-35% / -16%-23% / -9%-16% / -5%-12% / -3%

Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.

Bull Case

The case for BCPC:

  • As an established S&P 500 member in Materials, it brings scale and a long operating history.
Bear Case

The case against BCPC:

  • Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Key Risks
Research

Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.

Investment Thesis
Research

On balance, the picture is mixed: Balchem Corp is a small-cap materials business growing at a mature pace, with modest profitability, and a heavier debt load to watch. It trades at n/a earnings, which our model scores Unrated (0/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.

Analyst Ratings

What 9 Wall Street analysts covering BCPC recommend (July 2026). Consensus is a useful sanity check — not a substitute for your own homework.

Buy
consensus · score 4.0 / 5 across 9 analysts
Strong Buy 2Buy 5Hold 2Sell 0Strong Sell 0

Latest SEC Filings

BCPC's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.

BCPC — frequently asked questions

Is BCPC a good stock to buy?

We don't give buy or sell advice. Review Balchem Corp's fundamentals, valuation, and 5-year financials on this page, then make your own decision — and consider a licensed professional.

Where does BCPC's data come from?

Live price data plus real fundamentals and 5-year financials pulled directly from Balchem Corp's SEC filings — refreshed automatically, not hand-entered.

How is the 5-year projection for BCPC calculated?

It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.

Is this BCPC analysis financial advice?

No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell BCPC. Always do your own research and consider a licensed professional.

Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.

Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.